The prevalence and risk of immune restoration disease in HIV-infected patients treated with highly active antiretroviral therapy.
about
HIV & immune reconstitution inflammatory syndrome (IRIS)Treatment guidelines and prognosis of immune reconstitution inflammatory syndrome patients: a reviewDrug reaction with eosinophilia and systemic symptoms (DRESS): incidence, pathogenesis and management.Hospital days attributable to immune reconstitution inflammatory syndrome in persons living with HIV before and after the 2012 DHHS HIV guidelines.Immune reconstitution inflammatory syndrome among HIV-infected South African infants initiating antiretroviral therapy.Risk factor analyses for immune reconstitution inflammatory syndrome in a randomized study of early vs. deferred ART during an opportunistic infectionA non-synonymous polymorphism in IL-23R Gene (rs1884444) is associated with reduced risk to schistosomiasis-associated Immune Reconstitution Inflammatory Syndrome in a Kenyan population.Incidence and predictors of immune reconstitution inflammatory syndrome in a rural area of Mozambique.d-Dimer and CRP levels are elevated prior to antiretroviral treatment in patients who develop IRIS.Factors associated with paradoxical immune response to antiretroviral therapy in HIV infected patients: a case control study.Rate and determinants of treatment response to different antiretroviral combination strategies in subjects presenting at HIV-1 diagnosis with advanced diseaseEvaluation of cellular phenotypes implicated in immunopathogenesis and monitoring immune reconstitution inflammatory syndrome in HIV/leprosy cases.Incidence, clinical spectrum, risk factors and impact of HIV-associated immune reconstitution inflammatory syndrome in South Africa.Immune restoration disease and changes in CD4+ T-cell count in HIV- infected patients during highly active antiretroviral therapy at Zewditu memorial hospital, Addis Ababa, Ethiopia.Insights into pathogenic events of HIV-associated Kaposi sarcoma and immune reconstitution syndrome related Kaposi sarcoma.Paradoxical immune reconstitution inflammatory syndrome in HIV-infected patients treated with combination antiretroviral therapy after AIDS-defining opportunistic infection.Parasitic infections in HIV infected individuals: diagnostic & therapeutic challengesOutcomes among HIV-1 infected individuals first starting antiretroviral therapy with concurrent active TB or other AIDS-defining disease.Pathogenesis and prevention of immune reconstitution disease during antiretroviral therapy.Immune reconstitution inflammatory syndrome (IRIS): review of common infectious manifestations and treatment options.High Initial HIV/AIDS-Related Mortality and -Its Predictors among Patients on Antiretroviral Therapy in the Kagera Region of Tanzania: A Five-Year Retrospective Cohort StudyImmune reconstitution inflammatory syndrome: more answers, more questions.Immune reconstitution inflammatory syndrome in human immunodeficiency virus-infected children in Peru.Intensification of antiretroviral therapy through addition of enfuvirtide in naive HIV-1-infected patients with severe immunosuppression does not improve immunological response: results of a randomized multicenter trial (ANRS 130 Apollo)Immune reconstitution disease associated with parasitic infections following antiretroviral treatment.HIV-1 tuberculosis-associated immune reconstitution inflammatory syndromeSub-optimal CD4 reconstitution despite viral suppression in an urban cohort on antiretroviral therapy (ART) in sub-Saharan Africa: frequency and clinical significanceImpact of the immune reconstitution inflammatory syndrome (IRIS) on mortality and morbidity in HIV-infected patients in Mexico.Interferon- alpha and - beta restrict polyomavirus JC replication in primary human fetal glial cells: implications for progressive multifocal leukoencephalopathy therapy.Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trialPolychromatic immunophenotypic characterization of T cell profiles among HIV-infected patients experiencing immune reconstitution inflammatory syndrome (IRIS).The prognosis of late presenters in the era of highly active antiretroviral therapy in serbia.Increased risk of genital ulcer disease in women during the first month after initiating antiretroviral therapyPoor CD4 recovery and risk of subsequent progression to AIDS or death despite viral suppression in a South African cohort.Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysisAn official ATS workshop report: Emerging issues and current controversies in HIV-associated pulmonary diseases.Unmasking Immune Reconstitution Inflammatory Syndrome (IRIS): A report of five cases and review of the literature.The immune reconstitution inflammatory syndrome related to HIV co-infections: a review.Urban legends series: oral manifestations of HIV infection.Clinical markers of immunodeficiency and mechanism of immune reconstitution inflammatory syndrome and highly active antiretroviral therapy on HIV: workshop 3A.
P2860
Q26852805-58456EFB-1283-47D7-A2D3-201E54EB81D8Q28081975-BA98BD88-BD6E-448B-B4BD-5A289DEC4BFDQ30240144-33A8D9B7-F994-4D8B-ACFA-6624D11F564FQ30252460-261E92D3-389F-452D-9C49-310859B8FC53Q33605245-C3104316-A3D9-4D10-865D-64F0DE5409D0Q33628799-7BC2F468-9E1F-4464-868C-08659BD3E859Q33756118-F64B3688-43C6-4976-AAFE-D4A657A67EC8Q33840983-9D36D6BD-64CD-4518-AB76-100ADD25E539Q33941296-8A0AE576-EBB9-46DE-9909-6A69943F464DQ34065045-FADE21C9-E8E0-4AC3-8537-8DC8657E174CQ34100037-8A64B16D-D589-4AED-902C-DD1E49AF6A9CQ34113607-15E254B4-9FA5-456F-B562-DD23B72051FBQ34477198-BF044750-1378-4ED6-86DE-F3885D9D186FQ34499007-B474DEB2-4829-422D-A9C8-661EDB9E631DQ34587349-92B2E1B5-A8C9-4598-B4B8-9137AE9AEA91Q34633782-32D53E6B-0A07-48EE-8A40-9C6808BCB937Q34635675-C1F8E439-6EB3-45F9-ADDD-D015F1FD30E0Q35082553-9CA9E452-1328-499B-AA31-75F85E41A96BQ35656939-E1CA496D-2E47-47A1-8E75-3AA4627D738BQ35799766-497DE433-5C69-467F-A820-36A16D679114Q36220774-50E6152A-8BF0-4CCE-943C-FE1D912AC564Q36342114-81D7CABF-7790-4F6D-B4AD-47E792C510BEQ36445405-D690CF27-3A19-4956-9719-57DEA3CEE9A3Q36558452-6E817DF6-6EF0-4F4A-841B-CF4A29AB9D37Q36624200-8220F5BE-8927-4205-8C5E-B63541FA7571Q36654015-73B8A0A2-8842-49A6-A2F1-715D5638050DQ37021073-1F11D2FF-5265-4863-A14D-CAEDF1462F4AQ37068212-F6647528-B6D2-4DCC-8A5E-7A55D9A9C86BQ37141540-247FC7E4-DFC9-409E-B9D2-41D53897746DQ37189075-8A22B074-991F-46AE-B2EE-0036E05E5A03Q37295455-A642C80D-9059-408C-B4C7-531254699D4AQ37416183-D79B3FDF-B3F6-4057-8101-BEE254322251Q37456199-F2EF6C55-A32C-4CC0-83BC-1646A8EF084EQ37617342-C3239A69-F2C3-4D43-9046-273816C6EC84Q37718319-43777C01-66F8-4962-8D14-CA615E841B33Q37848593-343C98E6-06EA-4581-9939-CBB4DC37E8E1Q37867506-27EF98BC-6238-4A35-8001-3DEDD63DBFFBQ37941459-2455D888-E977-45F5-854D-746E0C44C9E9Q38091715-6F711E28-037F-44F7-A3D9-DA8EAE06D21AQ39767247-5E461689-1740-429D-A09B-ED42083AA7B4
P2860
The prevalence and risk of immune restoration disease in HIV-infected patients treated with highly active antiretroviral therapy.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
The prevalence and risk of imm ...... active antiretroviral therapy.
@en
The prevalence and risk of imm ...... active antiretroviral therapy.
@nl
type
label
The prevalence and risk of imm ...... active antiretroviral therapy.
@en
The prevalence and risk of imm ...... active antiretroviral therapy.
@nl
prefLabel
The prevalence and risk of imm ...... active antiretroviral therapy.
@en
The prevalence and risk of imm ...... active antiretroviral therapy.
@nl
P2093
P2860
P1433
P1476
The prevalence and risk of imm ...... active antiretroviral therapy
@en
P2093
Djurković-Djaković O
Salemović D
P2860
P304
P356
10.1111/J.1468-1293.2005.00277.X
P50
P577
2005-03-01T00:00:00Z